1Belkhou Youssef, 2Benzakour Maria, 3Afkir Amine, 4Chabbar Sara, 5Zerhouni Amine, 6Fz Faouji, 7Mounir Anas, 8Bouhouri Aziz
ABSTRACT
Introduction : Hemorrhagic shock remains a leading cause of early mortality in polytraumatized patients. Early identification of high-risk patients is essential to optimize management and improve outcomes.
Materials and Methods : Retrospective review 200 polytraumatized patients admitted to a surgical ICU
Results : This retrospective study included 200 polytraumatized patients admitted with systolic blood pressure < 90 mmHg between 2020 and 2023. Patients were predominantly young and male. Abdominal and cranial injuries were the most frequent. Clinical severity markers included tachycardia, hypoxia, low Glasgow Coma Scale, urinary disturbances, and hypothermia. Severe anemia (hemoglobin < 5 g/dL), thrombocytopenia, and coagulation abnormalities were significantly associated with mortality. Overall mortality was 37.5%. Discussion : Poor prognosis was associated with age, trauma severity, abdominal or cranial injury, shock index > 0.9, neurological impairment, hypothermia, and major biological abnormalities. These findings are consistent with existing literature and highlight the importance of early severity assessment.
Conclusion : Early recognition of prognostic factors and optimization of prehospital and hospital trauma care are crucial to reduce mortality from hemorrhagic shock in polytraumatized patients.
KEYWORDS
Hemorrhagic shock / Polytrauma / Prognostic factors / Mortality / Massive transfusion / Prehospital care
REFERENCES
1) Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38(2):185–193.
2) Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations.
3) J Trauma. 2006;60(6 Suppl):S3–S11.
4) Cannon JW. Hemorrhagic shock. N Engl J Med. 2018;378(4):370–379.
5) Trunkey DD.
6) Trauma. Accidental and intentional injuries account for more years of life lost in the U.S. than cancer and heart disease.
7) Sci Am. 1983;249(2):28–35.
8) Dutton RP, Stansbury LG, Leone S, et al.
9) Trauma mortality in mature trauma systems: are we doing better?
10) Anesthesiology. 2010;113(2):293–299.
11) 6.Spahn DR, Bouillon B, Cerny V, et al.
12) The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition.
13) Crit Care. 2019;23:98.
14) Holcomb JB, Jenkins D, Rhee P, et al.
15) Damage control resuscitation: directly addressing the early coagulopathy of trauma.
16) J Trauma. 2007;62(2):307–310.
17) Guyton AC, Hall JE.
18) Textbook of Medical Physiology. 13th ed.
19) Philadelphia: Elsevier Saunders; 2016.
20) (Chapitre : circulatory shock)
21) 9.Egan TD, Shafer SL.
22) Target-controlled infusions for intravenous anesthetics: pharmacokinetic and pharmacodynamic considerations.
23) Anesthesiology. 2003;99(5):1211–1219.
24) 10.Charbit J, Tessler MJ, et al.
25) Prognostic value of shock index in the initial assessment of trauma patients.
26) Br J Anaesth. 2010;104(6):734–739.
27) 11.Jansen TC, van Bommel J, Schoonderbeek FJ, et al.
28) Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial.
29) Am J Respir Crit Care Med. 2010;182(6):752–761.
30) 12. CRASH-2 trial collaborators.
31) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
32) Lancet. 2010;376(9734):23–32.
